1. Contractors
  2. Orexo US Inc

Orexo US Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Orexo US has 1 federal contract of $100,000 or more active since October 2023, with $11.5M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
1 since FY2024$11,450,712 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Office of Assistant Secretary for Preparedness and Response$11.5M on 1 contract
UEI
MN1MPMBCVVD5Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Clinical Development of OX390 (Atipamezole) As an ?2 Agonist Reversal Agent for Human Use to Counteract the Sedative Effects of Xylazine, Medetomidine, and Other ?2 AgonistsOffice of Assistant Secretary for Preparedness and Response · 75A50125C00010$11,450,712Dec 31, 2027in 13 monthsNJ

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Office of Assistant Secretary for Preparedness and Response1 contract$11,450,712

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract$11,450,712

Where the work is

Place of workAmount
New Jersey1 contract$11,450,712

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Office of Assistant Secretary for Preparedness and Response: see the list.

Get new notices like Orexo US's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy